Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 2
1986 2
1993 1
1997 1
1998 1
1999 3
2000 1
2002 2
2003 4
2004 1
2006 1
2007 4
2008 3
2009 2
2010 5
2011 6
2012 6
2013 2
2014 3
2015 13
2016 10
2017 11
2018 6
2019 10
2020 8
2021 14
2022 18
2023 18
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
In an 8-week, phase 2 trial, sparsentan, a dual endothelin-angiotensin receptor antagonist, reduced proteinuria in patients with FSGS. The efficacy and safety of longer-term treatment with sparsentan for FSGS are unknown. METHODS: In this phase 3 trial, we enrolled patient …
In an 8-week, phase 2 trial, sparsentan, a dual endothelin-angiotensin receptor antagonist, reduced proteinuria in patients with FSGS. The e …
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.
Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar AK, Parkhomenko AN, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne KP, Fox KAA, Yusuf S; COMPASS Investigators. Moayyedi P, et al. Among authors: anand ss. Gastroenterology. 2019 Sep;157(3):682-691.e2. doi: 10.1053/j.gastro.2019.05.056. Epub 2019 May 29. Gastroenterology. 2019. PMID: 31152740 Clinical Trial.
BACKGROUND & AIMS: Proton pump inhibitors (PPIs) are effective at treating acid-related disorders. These drugs are well tolerated in the short term, but long-term treatment was associated with adverse events in observational studies. ...
BACKGROUND & AIMS: Proton pump inhibitors (PPIs) are effective at treating acid-related disorders. These drugs are well tolerated in the …
Duplication Cyst.
Anand S, Aleem A. Anand S, et al. 2022 Oct 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2022 Oct 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 33232017 Free Books & Documents.
The definitive treatment modality for children with a duplication cyst is surgery. Excellent long-term outcomes are reported after optimal surgery....
The definitive treatment modality for children with a duplication cyst is surgery. Excellent long-term outcomes are reported after op …
Epispadias.
Anand S, Lotfollahzadeh S. Anand S, et al. 2023 Jun 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jun 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 33085327 Free Books & Documents.
The most important factor determining postoperative continence in these patients is the availability of a skilled pediatric surgeon/urologist. Long-term follow-up is necessary to address the psychosexual issues during the transition from childhood to adolescence and adulth …
The most important factor determining postoperative continence in these patients is the availability of a skilled pediatric surgeon/urologis …
Intracranial pressure monitoring in patients with acute brain injury in the intensive care unit (SYNAPSE-ICU): an international, prospective observational cohort study.
Robba C, Graziano F, Rebora P, Elli F, Giussani C, Oddo M, Meyfroidt G, Helbok R, Taccone FS, Prisco L, Vincent JL, Suarez JI, Stocchetti N, Citerio G; SYNAPSE-ICU Investigators. Robba C, et al. Lancet Neurol. 2021 Jul;20(7):548-558. doi: 10.1016/S1474-4422(21)00138-1. Lancet Neurol. 2021. PMID: 34146513 Free article.
The aims of this study were to describe current ICP monitoring practises for patients with acute brain injury at centres around the world and to assess variations in indications for ICP monitoring and interventions, and their association with long-term patient outcomes. ME …
The aims of this study were to describe current ICP monitoring practises for patients with acute brain injury at centres around the world an …
The Relationship Between Diet, Gut Microbiota, and Serum Metabolome of South Asian Infants at 1 Year.
Bruce CY, Shanmuganathan M, Azab SM, Simons E, Mandhane P, Turvey SE, Subbarao P, Azad MB, Britz-McKibbin P, Anand SS, de Souza RJ, Stearns JC. Bruce CY, et al. Among authors: anand ss. J Nutr. 2023 Feb;153(2):470-482. doi: 10.1016/j.tjnut.2022.12.016. Epub 2022 Dec 27. J Nutr. 2023. PMID: 36894240 Free article.
Infancy is an important developmental period that may influence a person's long-term health. Infant development can be affected by diet, which also interacts with the developing gut microbiota. ...METHODS: We derived dietary patterns of 1-y-old infants (n = 182) participat …
Infancy is an important developmental period that may influence a person's long-term health. Infant development can be affected by di …
Use of race, ethnicity, and ancestry data in health research.
Lu C, Ahmed R, Lamri A, Anand SS. Lu C, et al. Among authors: anand ss. PLOS Glob Public Health. 2022 Sep 15;2(9):e0001060. doi: 10.1371/journal.pgph.0001060. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962630 Free PMC article. Review.
Although race, ethnicity, and ancestry are often treated synonymously, they should be considered as distinct terms in the context of health research. Researchers should carefully consider which term is most appropriate for their study, define and use the terms consistently …
Although race, ethnicity, and ancestry are often treated synonymously, they should be considered as distinct terms in the context of health …
Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis.
Wong AYS, Chan EW, Anand S, Worsley AJ, Wong ICK. Wong AYS, et al. Among authors: anand s. Drug Saf. 2017 Aug;40(8):663-677. doi: 10.1007/s40264-017-0533-2. Drug Saf. 2017. PMID: 28397186 Review.
A meta-analysis was conducted to investigate the short- and long-term risks of cardiovascular mortality, myocardial infarction, arrhythmia, and stroke. ...CONCLUSIONS: More studies are required to investigate the short-term cardiovascular outcomes associated with di …
A meta-analysis was conducted to investigate the short- and long-term risks of cardiovascular mortality, myocardial infarction, arrhy …
Publication landscape of Posterior urethral valve- A scientometric study.
Dhua AK, Anand S, Goel P, Yadav DK, Jain V, Verma A. Dhua AK, et al. Among authors: anand s. J Pediatr Urol. 2022 Oct;18(5):650-660. doi: 10.1016/j.jpurol.2022.08.020. Epub 2022 Aug 30. J Pediatr Urol. 2022. PMID: 36167650 Review.
The top-cited documents (n = 10) received 2104 citations and were published between 1986 and 2010. The key areas of interest found were "long-term outcomes" (n = 4) and "fetal surgery" (n = 2). The most productive countries were also the most collaborative countries (the U …
The top-cited documents (n = 10) received 2104 citations and were published between 1986 and 2010. The key areas of interest found were "lon …
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial.
Eikelboom JW, Bosch J, Connolly SJ, Tyrwitt J, Fox KAA, Muehlhofer E, Neumann C, Tasto C, Bangdiwala SI, Diaz R, Alings M, Dagenais GR, Leong DP, Lonn EM, Avezum A, Piegas LS, Widimsky P, Parkhomenko AN, Bhatt DL, Branch KRH, Probstfield JL, Lopez-Jaramillo P, Rydén L, Pogosova N, Keltai K, Keltai M, Ertl G, Stoerk S, Dans AL, Lanas F, Liang Y, Zhu J, Torp-Pedersen C, Maggioni AP, Commerford PJ, Guzik TJ, Vanassche T, Verhamme P, O'Donnell M, Tonkin AM, Varigos JD, Vinereanu D, Felix C, Kim JH, Ibrahim KS, Lewis BS, Metsarinne KP, Aboyans V, Steg PG, Hori M, Kakkar A, Anand SS, Lamy A, Sharma M, Yusuf S. Eikelboom JW, et al. Among authors: anand ss. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 2;8(8):786-795. doi: 10.1093/ehjcvp/pvac023. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 35383832 Clinical Trial.
AIMS: To describe outcomes of patients with chronic coronary artery disease (CAD) and/or peripheral artery disease (PAD) enrolled in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) randomized trial who were treated with the combination of rivarox …
AIMS: To describe outcomes of patients with chronic coronary artery disease (CAD) and/or peripheral artery disease (PAD) enrolled in the Car …
138 results